On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, 2024-2025 president of the National Foundation for Infectious Diseases, on the recent report from the World Health Organization and UNICEF on public immunization rates, with national and global health implications.
On this episode of Managed Care Cast, we speak with Jeffery A. Goad, PharmD, MPH, professor of pharmacy at the Chapman University School of Pharmacy in Irvine, California; a fellow of the American Society of Health-System Pharmacists; and 2024-2025 president of the National Foundation for Infectious Diseases.
On July 16, the World Health Organization (WHO) and UNICEF released their latest public immunization data, and in this interview, Goad addresses how these 2023 data compare with 2019 baseline data (pre-COVID-19), the vital role of vaccine distribution infrastructure and its impact on health care equity, repercussion on national and global infant mortality rates, potential public policy implications, and the importance of community pharmacists to tackling vaccine misinformation.
Listen above or on one of these podcast services:
Redefining Long COVID Care With Personalized Treatment
March 20th 2025To mark the 5-year anniversary of the COVID pandemic, The American Journal of Managed Care® spoke with Noah Greenspan, DPT, PT, CCS, EMT-B, cardiopulmonary physical therapist and director of the Pulmonary Wellness and Rehabilitation Center in New York City.
Read More
Navigating Sport-Related Neurospine Injuries, Surgery, and Managed Care
February 25th 2025On this episode of Managed Care Cast, we speak with Arthur L. Jenkins III, MD, FACS, CEO of Jenkins NeuroSpine, to explore the intersection of advanced surgical care for sport-related neurospine injuries and managed care systems.
Listen
Varied Access: The Pharmacogenetic Testing Coverage Divide
February 18th 2025On this episode of Managed Care Cast, we speak with the author of a study published in the February 2025 issue of The American Journal of Managed Care® to uncover significant differences in coverage decisions for pharmacogenetic tests across major US health insurers.
Listen
For Neuromuscular Disease Community, an Era of Opportunities and Threats
March 17th 2025Robert Califf, MD, former commissioner of the FDA, delivered a keynote address at the 2025 Muscular Dystrophy Association Clinical & Scientific Conference that highlighted the enormous opportunities for progress in neuromuscular disease care amid a changing policy environment.
Read More